Relationship between the pathogenesis of sarcoidosis and hepatitis C.
作者信息
Demirkok Sevtap Sipahi
出版信息
World J Gastroenterol. 2007 Mar 28;13(12):1883-4. doi: 10.3748/wjg.v13.i12.1883.
Abstract
摘要
相似文献
1
Relationship between the pathogenesis of sarcoidosis and hepatitis C.
World J Gastroenterol. 2007 Mar 28;13(12):1883-4. doi: 10.3748/wjg.v13.i12.1883.
2
Sarcoidosis developing after treatment with interferon alpha in a patient with hepatitis C: An association every physician should know.
Rev Gastroenterol Mex. 2017 Apr-Jun;82(2):185-186. doi: 10.1016/j.rgmx.2016.01.005. Epub 2016 May 6.
3
[Sarcoidosis associated with the treatment of hepatitis C: case report and Spanish literature review].
Med Clin (Barc). 2011 May 21;136(14):649-50. doi: 10.1016/j.medcli.2010.06.021. Epub 2010 Nov 3.
4
Asymptomatic systemic sarcoidosis arising 5 years after IFN-alpha treatment for chronic hepatitis C: a new challenge for clinicians.
J Interferon Cytokine Res. 2004 Nov;24(11):655-8. doi: 10.1089/jir.2004.24.655.
5
Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantation.
Transpl Infect Dis. 2008 Jun;10(3):184-9. doi: 10.1111/j.1399-3062.2007.00258.x. Epub 2007 Oct 1.
6
Sarcoidosis and hepatitis C: clinical description of 11 cases.
Eur J Gastroenterol Hepatol. 2010 Aug;22(8):967-72. doi: 10.1097/MEG.0b013e32833834bc.
7
Sarcoidosis presenting as tattoo changes in a patient undergoing treatment with interferon-alpha and ribavirin.
Clin Exp Dermatol. 2004 Sep;29(5):547-8. doi: 10.1111/j.1365-2230.2004.01575.x.
8
Facial cosmetic filler injections as possible target for systemic sarcoidosis in patients treated with interferon for chronic hepatitis C: two cases.
Dermatology. 2008;217(1):81-4. doi: 10.1159/000128281. Epub 2008 Apr 29.
9
A 49-year-old woman with hepatitis, confusion, and abnormal chest radiograph findings.
Chest. 2005 Oct;128(4):3076-7, 3078-9. doi: 10.1378/chest.128.4.3076.
10
Development of cutaneous sarcoidosis in a patient with chronic hepatitis C treated with interferon alpha 2b.
J Cutan Med Surg. 2001 Sep-Oct;5(5):406-8. doi: 10.1177/120347540100500507.
本文引用的文献
1
Sarcoidosis after treatment with interferon-alpha: a case series and review of the literature.
Respir Med. 2006 Nov;100(11):2063-8. doi: 10.1016/j.rmed.2006.03.004. Epub 2006 May 3.
2
Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptive immunity.
Intern Med. 2006;45(4):183-91. doi: 10.2169/internalmedicine.45.1530. Epub 2006 Mar 15.
3
Spontaneous resolution of systemic sarcoidosis in a patient with chronic hepatitis C without interferon therapy.
World J Gastroenterol. 2006 Jan 7;12(1):150-3. doi: 10.3748/wjg.v12.i1.150.
4
Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C--a case report and review of the literature.
Acta Gastroenterol Belg. 2005 Oct-Dec;68(4):432-4.
5
Sarcoidosis caused by interferon therapy.
Respirology. 2005 Sep;10(4):535-40. doi: 10.1111/j.1440-1843.2005.00746.x.
6
The prevalence of hepatic granulomas in chronic hepatitis C.
J Clin Gastroenterol. 2004 May-Jun;38(5):449-52. doi: 10.1097/00004836-200405000-00011.
7
Hepatic granulomas: a 10 year single centre experience.
J Clin Pathol. 2003 Nov;56(11):850-3. doi: 10.1136/jcp.56.11.850.
8
The dermatopathologic manifestations of hepatitis C infection: a clinical, histological, and molecular assessment of 35 cases.
Hum Pathol. 2003 Jun;34(6):573-9. doi: 10.1016/s0046-8177(03)00193-x.
9
The prevalence of serum antibodies to hepatitis C virus is not increased in patients with sarcoidosis.
Respiration. 2000;67(5):592. doi: 10.1159/000029581.
10
Sarcoidosis: immunopathogenetic concepts and their clinical application.
Eur Respir J. 1998 Sep;12(3):716-38. doi: 10.1183/09031936.98.12030716.
Zotero 插件